Meeting Report: Psoriasis Stratification to Optimise Relevant Therapy Showcase.

Abstract A stratified medicine approach for the treatment of psoriasis promises greater certainty of clinical decision making through prediction of response based on clinical, pharmacological, and -omics data from an individual patient. As yet, there is no predictive model for treatment response in routine clinical use for psoriasis. The Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium is a UK Medical Research Council funded, academic-industrial stratified medicine consortium established with the objective of discovering predictors and stratifiers of response of psoriasis to biologic therapies. A showcase meeting was convened and attended by 80 stakeholders at the Royal College of Physicians, London on 18th November 2019. The purpose was to disseminate the research findings from the PSORT consortium discovered thus far. This report summarises the presentations made on the day and the significant advances made by PSORT towards a stratified medicine approach to the management of psoriasis.